AUTO4
Autolus Therapeutics
['ptcl', 'lymsm', 'lymphoma', 'leusm']
#17icml describes the clinical findings of auto4, a car t-cell product targeting trbc1 for patients with trbc1-positive ptcl. follow-up data show auto4 was well tolerated without dose limiting toxicity. the study is ongoing to define phase 2 dose #lymsm #leusm #lymphoma 
A global education platform providing clinical updates on a range of lymphoma subtypes and chronic lymphocytic leukemia (#CLL) #lymsm